SABVIT CAPSULES

Indications

• Support for cognitive function
• Cardiovascular health
• Anti-inflammatory effects
• Eye health
• Neuroprotection

Dosage

Children: Refer to specific product guidelines or clinical recommendations for dosage.

Adults: Refer to specific product guidelines or clinical recommendations for dosage.

Mechanism of action

DHA is incorporated into cell membranes, particularly in the brain and retina, where it contributes to membrane fluidity and function. It serves as a precursor for the synthesis of neuroprotective and anti-inflammatory mediators, including resolvins and protectins, which help to modulate inflammatory responses and promote neuronal health.

Pharmacodynamics

DHA influences various physiological processes, including lipid metabolism, inflammation, and neuronal signaling. It has been shown to enhance synaptic plasticity and cognitive functions, and it may exert cardioprotective effects by improving endothelial function and reducing triglyceride levels. DHA also plays a role in the modulation of gene expression related to inflammation and lipid metabolism.

Pharmacokinetics

DHA is absorbed from the gastrointestinal tract and distributed throughout the body, particularly to the brain and retina. Its bioavailability can be influenced by dietary factors and the presence of other fatty acids. Metabolism occurs primarily through beta-oxidation and incorporation into phospholipids, with elimination taking place via the bile and urine. The half-life of DHA varies, but its effects can be prolonged due to incorporation into tissue.

Adverse effects

• Nausea
• Diarrhea
• Gastrointestinal discomfort
• Increased bleeding tendency
• Allergic reactions

Interactions

• Anticoagulants (e.g., warfarin) - may increase the risk of bleeding
• Antiplatelet drugs - may enhance the effects of these medications

Precautions

• Use caution in patients with a known allergy to fish or shellfish
• Monitor bleeding in patients taking anticoagulants or antiplatelet medications
• Consult healthcare provider before use in patients with liver disease

Pregnancy

DHA is generally considered safe during pregnancy, but high doses should be avoided unless prescribed by a healthcare provider.

Breast-feeding

DHA is beneficial during breastfeeding, as it can support infant brain development, but consult a healthcare provider for dosage.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Softgel capsules
• Liquid fish oil
• Fortified foods and beverages

Indications

• Allergic conditions
• Autoimmune diseases
• Asthma and chronic obstructive pulmonary disease (COPD)
• Certain cancers (e.g., leukemia, lymphoma)
• Skin conditions (e.g., dermatitis)
• Inflammatory bowel disease
• Multiple sclerosis exacerbations
• Severe infections requiring immunosuppression

Dosage

Children: Refer to BNF for Children for specific dosing; doses vary significantly based on the child's age, weight, and condition being treated.

Adults: Refer to BNF for specific dosing; typically, initial doses range from 4 to 48 mg depending on the severity of the condition.

Mechanism of action

Methylprednisolone exerts its effects by binding to glucocorticoid receptors, leading to the modulation of gene expression. This interaction influences the transcription of anti-inflammatory proteins while suppressing the expression of pro-inflammatory genes, ultimately resulting in reduced inflammation and immune response.

Pharmacodynamics

The pharmacodynamic effects of methylprednisolone are characterized by its ability to decrease inflammation, suppress the immune response, and affect carbohydrate metabolism. Therapeutic doses lead to various systemic effects, including modification of leukocyte distribution and inhibition of cytokine production.

Pharmacokinetics

Methylprednisolone is well absorbed after oral administration, with a bioavailability of approximately 50%. It has a volume of distribution that reflects extensive tissue binding. The drug is metabolized primarily in the liver through conjugation and reduction, and its metabolites are excreted in urine. The half-life varies based on the route of administration but is generally around 18 to 36 hours.

Adverse effects

• Increased blood pressure
• Hyperglycemia
• Weight gain
• Mood changes
• Insomnia
• Gastrointestinal disturbances
• Increased susceptibility to infections

Interactions

• methylphenidate+apraclonidine: Severe (decreases effects)
• methylthioninium chloride+bupropion: Severe (increases risk of severe hypertension)
• methylphenidate+linezolid: Severe (increases risk of elevated blood pressure)
• rasagiline+methylphenidate: Severe (increases risk of a hypertensive crisis)
• mao-inhibitors+methylphenidate: Severe (increases risk of a hypertensive crisis)
• dronedarone+methylprednisolone: Moderate (increases exposure)
• miconazole+methylprednisolone: Moderate (increases concentration)
• antifungals, azoles+methylprednisolone: Moderate (increases exposure)
• crizotinib+methylprednisolone: Moderate (increases exposure)

Precautions

• Use with caution in patients with hypertension
• Monitor blood glucose levels in diabetic patients
• Consider potential for infection risk due to immunosuppression
• Evaluate for psychiatric effects in susceptible individuals

Pregnancy

Corticosteroids may be used during pregnancy if the potential benefit justifies the risk to the fetus. Careful monitoring is advised.

Breast-feeding

Corticosteroids are excreted in breast milk; caution is advised. Monitor the infant for potential effects.

Storage

Store in a cool, dry place, away from light. Keep out of reach of children.

Formulations

• Tablets
• Injectable solutions
• Topical preparations

Indications

• Vitamin B12 deficiency
• Megaloblastic anemia
• Peripheral neuropathy
• Neuropathic pain
• Multiple sclerosis

Dosage

Children: For paediatric patients, refer to the BNF for Children for appropriate dosing guidelines.

Adults: The typical adult dosage for methylcobalamin is 500 micrograms to 1,000 micrograms administered intramuscularly or subcutaneously, usually once daily for the initial treatment, followed by maintenance doses as needed.

Mechanism of action

Methylcobalamin serves as a cofactor for the enzyme methionine synthase, which catalyzes the conversion of homocysteine to methionine. This reaction is crucial in the synthesis of S-adenosylmethionine (SAMe), an important methyl donor in numerous methylation reactions within the body. Methylcobalamin also plays a role in myelin formation and the maintenance of nerve cells.

Pharmacodynamics

Methylcobalamin exhibits neuroprotective effects, promoting nerve regeneration and repair in peripheral neuropathy. It is believed to enhance nerve conduction and improve neurological function. The physiological effects are primarily attributed to its role in methylation processes and the synthesis of neurotransmitters.

Pharmacokinetics

Methylcobalamin is water-soluble and is absorbed in the intestine. The bioavailability can be affected by gastrointestinal health, and intrinsic factor is not required for its absorption. It is distributed throughout the body, with high concentrations in the liver, kidneys, and brain. The elimination half-life of methylcobalamin is approximately 6 hours, and it is excreted primarily in the urine.

Adverse effects

• Nausea
• Diarrhea
• Headache
• Dizziness
• Anxiety
• Rash
• Pruritus

Precautions

• Monitor patients with Leber's disease due to potential optic nerve damage.
• Caution in patients with allergies to cobalt or vitamin B12.
• Use with caution in patients with renal impairment.

Pregnancy

Methylcobalamin is classified as a category A drug. It is generally considered safe during pregnancy, but consultation with a healthcare provider is recommended.

Breast-feeding

Methylcobalamin is excreted in breast milk. It is generally considered safe during breastfeeding, but consultation with a healthcare provider is recommended.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Tablets
• Injections
• Sublingual tablets
• Oral solutions

Mechanism of action

Methylsulphate functions as a methylating agent, transferring a methyl group to nucleophiles. This process involves the formation of a sulfonium ion, which is highly reactive and can readily react with nucleophilic sites on various substrates, leading to methylation reactions.

Pharmacodynamics

The pharmacodynamics of methylsulphate is primarily related to its role as a methylating agent in biochemical reactions. It can alter the structure and function of biological molecules, potentially affecting cellular processes and signaling pathways. However, detailed pharmacodynamic studies specific to therapeutic use are limited.

Pharmacokinetics

There is limited information on the pharmacokinetics of methylsulphate, given its typical use as a reagent in laboratory settings rather than a clinical drug. When used in chemical reactions, its reactivity and transformation into other compounds would dictate its pharmacokinetic profile, which could vary significantly based on the specific context of use.

Pregnancy

There is limited data on the use of methylsulphate in pregnancy. Consult relevant guidelines.

Breast-feeding

Data on the excretion of methylsulphate in human milk is not available. Caution is advised.

Storage

Store in a cool, dry place, away from direct sunlight.

Indications

• Vitamin B6 deficiency
• Peripheral neuropathy
• Certain types of anemia
• Pyridoxine-dependent seizures
• Supplementation in pregnant women to alleviate nausea

Dosage

Children: Refer to established guidelines for specific dosing, as pyridoxal 5'-phosphate dosages can vary based on indication and patient-specific factors.

Adults: Refer to established guidelines for specific dosing, as pyridoxal 5'-phosphate dosages can vary based on indication and patient-specific factors.

Mechanism of action

Pyridoxal 5'-phosphate functions primarily as a coenzyme in various enzymatic reactions. It is involved in transamination, decarboxylation, and racemization reactions, facilitating the conversion of amino acids and the production of neurotransmitters. It also plays a role in the metabolism of tryptophan to niacin and the synthesis of sphingolipids.

Pharmacodynamics

The pharmacodynamic effects of pyridoxal 5'-phosphate are closely tied to its role as a cofactor in enzymatic reactions. Its deficiency can lead to neurological disorders, impaired immune function, and anemia. Adequate levels are associated with improved mood, cognitive function, and overall metabolic health.

Pharmacokinetics

Pyridoxal 5'-phosphate is absorbed in the intestine and is widely distributed throughout the body, including the brain. It is metabolized primarily in the liver, where it can be converted into other forms of vitamin B6. The elimination half-life is variable and can depend on individual metabolic rates. Excess vitamin B6 is excreted in urine as pyridoxal and pyridoxic acid.

Adverse effects

• Peripheral neuropathy
• Photosensitivity
• Gastrointestinal disturbances
• Nausea
• Headache
• Drowsiness

Interactions

• May interact with certain antiepileptic drugs, potentially reducing their effectiveness
• May affect the metabolism of levodopa, reducing its effectiveness
• Can interact with isoniazid, potentially reducing the effectiveness of pyridoxine therapy

Precautions

• Use caution in patients with liver disease
• Monitor for neuropathy with prolonged use
• Consider vitamin B6 status in patients with malabsorption syndromes

Pregnancy

Pyridoxal 5'-phosphate is generally considered safe during pregnancy when used at recommended doses.

Breast-feeding

Pyridoxal 5'-phosphate is excreted in breast milk, but is considered safe for breastfeeding mothers when used at recommended doses.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Tablets
• Capsules
• Injectable solutions

Indications

• Megaloblastic anemia
• Macrocytic anemia
• Topical sprue
• Hematologic complications due to folate deficiency

Dosage

Children: Refer to the BNF for Children for specific paediatric dosing information.

Adults: Refer to the BNF for specific dosing recommendations based on the condition being treated.

Mechanism of action

Tetrahydrofolate is transported across cells by receptor-mediated endocytosis. Once inside, it is critical for maintaining normal erythropoiesis, synthesizing purine and thymidylate nucleic acids, interconverting amino acids, methylating tRNA, and generating and utilizing formate.

Pharmacodynamics

Tetrahydrofolate acts as a coenzyme in many reactions involving the transfer of single carbon groups. Its deficiency affects nucleic and amino acid synthesis, primarily impacting actively dividing and growing cells. This compound is crucial for the treatment of conditions such as megaloblastic anemia and sprue, highlighting its importance in cellular metabolism.

Pharmacokinetics

Tetrahydrofolate is primarily absorbed in the intestines after the dietary intake of folate. It is distributed throughout the body and has a relatively short half-life. The compound is metabolized and utilized in various cellular processes, with excess being excreted via the urine. The pharmacokinetic profile is influenced by the body’s folate status and dietary intake.

Pregnancy

Tetrahydrofolate is considered safe during pregnancy and is essential for fetal development, particularly for preventing neural tube defects.

Breast-feeding

Tetrahydrofolate is excreted in breast milk, but at levels unlikely to affect a nursing infant adversely.

Storage

Store in a cool, dry place away from light, and keep out of reach of children.

Formulations

• Tablets
• Injection

Mechanism of action

Tetrahydrofolate is transported across cells by receptor-mediated endocytosis where it is needed to maintain normal erythropoiesis, synthesize purine and thymidylate nucleic acids, interconvert amino acids, methylate tRNA, and generate and use formate.

Pharmacodynamics

Tetrahydrofolate is the main active metabolite of dietary folate. It is vital as a coenzyme in reactions involving transfers of single carbon groups. Tetrahydrofolate has a role in nucleic and amino acid synthesis. As nucleic and amino acid synthesis is affected by a deficiency of tetrahydrofolate, actively dividing and growing cells tend to be the first affected. Tetrahydrofolate is used to treat topical sprue and megaloblastic and macrocytic anemias, hematologic complications resulting from a deficiency in folic acid.